Documents
Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 1000MG | 2 | FERRIPROX | DEFERIPRONE |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | AP | 2020-05-19 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2021-11-30 | STANDARD |
Submissions Property Types
CDER Filings
CHIESI
cder:Array
(
[0] => Array
(
[ApplNo] => 212269
[companyName] => CHIESI
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/212266s000lbl.pdf#page=14"]
[products] => [{"drugName":"FERRIPROX","activeIngredients":"DEFERIPRONE","strength":"1GM","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"05\/19\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/212266s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"05\/19\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/212266s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/212269Orig1s000replacementltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2020-05-19
)
)